Lee Pelton Revealed Alzheimer's Diagnosis
The former Boston Foundation leader shared his diagnosis in a personal essay to raise awareness for the disease.
Updated on Oct. 14, 2026 in Alzheimer’s
Lee Pelton, the former president and CEO of The Boston Foundation, has announced that he is living with Alzheimer's disease. He shared the news in a personal essay published in The Boston Globe to bring public attention to the condition.
Why it matters
Pelton, a prominent civic figure, chose to disclose his diagnosis to advocate for Alzheimer's awareness and to honor his mother, who died from the disease. His decision highlights the personal impact of a condition that remains a significant public health challenge.
Pelton was recognized as one of the 50 most powerful nonprofit leaders in 2024 by The NonProfit Times and received the Harvard Medal that same year. He also held a ranking on the list of the 150 most influential Bostonians.
The players
Lee Pelton
He is the former president and CEO of The Boston Foundation, a former president of Emerson College, and a current member of the GBH Board of Trustees.
The Boston Foundation
This is a philanthropic organization in Boston that supports community initiatives and nonprofits through grantmaking and civic leadership.
The details
Pelton decided to go public after experiencing a noticeable decline in his short-term memory that increased in intensity over recent weeks. He remains an active member of the community, currently serving on the GBH Board of Trustees.
Timeline
In 2024, Pelton was named an influential nonprofit leader and received the Harvard Medal.
In September 2026, Pelton stepped down as CEO of The Boston Foundation.
On October 14, 2026, Pelton discussed his essay on Boston Public Radio.
Health Landscape
Pelton's disclosure follows a pattern set by other public figures who use their status to raise awareness for neurodegenerative conditions. This shift contributes to a broader cultural movement of destigmatizing Alzheimer's and similar diseases in the public eye.
This news highlights the reality that memory impairment can affect even high-profile professionals, prompting discussions about early detection. Residents are encouraged to recognize symptoms like short-term memory decline and consult medical professionals early.
The takeaway
Pelton's essay serves as a call for increased public discourse surrounding Alzheimer's and the importance of early diagnosis. His story demonstrates how personal advocacy can influence public understanding of degenerative neurological conditions.
Further reading
Learn more about local support networks by visiting the Alzheimer’s section.
Source note: This article includes information reported by GBH.
